Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and ...

CRISPR Therapeutics › Investing in modestly sized growth stocks can lead to significant returns, but oftentimes it requires ...

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam ...

List today: Adherex Technologies FENC is a clinical-stage biotechnology company which is focused on the development of Sodium ...

Reliance Industries, Infosys, Tech Mahindra, Wipro, HDFC Bank, IRFC, Nestle India, HCL Tech, IREDA among marquee companies to ...

MFN-driven drug price reductions in the US are unlikely to have a big impact pharma R&D spending, experts agree.

In a world where traditional asset classes face persistent volatility, many high net worth investors are looking beyond equities and bonds for new sources of diversification and returns. This is where ...

Virtual fencing and feed management tech led were among the top-funded focus areas in the third quarter of this year.

Beijing is stacking up its bargaining chips ahead of expected U.S.-China talks when Presidents Donald Trump and Xi Jinping ...

Top Universities Leading the Charge in Billionaire Alumni 1. Harvard University: The Birthplace of Tech Titans and Business ...

The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic. Click here for ...

Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, ...